Acolad, the global leader in content and language solutions, is announcing the launch of its brand-new connector for Veeva Vault, which automates translation requests and deliveries through a direct connection between Acolad’s own system and Veeva Vault.
“Through this new connector we will be able to offer our customers a seamless integration between the Acolad ecosystem and Veeva Vault.” states Frédéric Queudret, Chief AI and Technology Officer at Acolad. “We are expecting to see a considerable reduction in manual processes via this new automation, which also will positively impact quality, time-to-market, and costs for the adopters.”
The new connectivity option will be available for Acolad Life Sciences customers who utilize Veeva Vault, an enterprise cloudplatform specifically built for the life sciences industry that uniquely manages both content and data. It helps biopharmaceutical companies eliminate silos and seamlessly execute end-to-end processes across clinical, regulatory, quality, safety, commercial, and medical.
With a history of more than 30 years, and a global footprint spanning 23 countries, Acolad’s expertise in worldwide medical and pharma communications is unmatched, providing translation and content services to the Life Sciences industry with an uncompromising commitment to quality.
For more information see here.
***
About Acolad
Acolad is the global leader in content and language solutions. Its mission is to support companies in every industry to scale across markets and enable growth through cutting-edge technology and localization expertise. Established in 1993, the group is present in 25 countries across Europe, North America, and Asia, with over 1.800 employees supported by a network of +20.000 linguists around the world. www.acolad.com
